- Home
- TTSH vs ACIU Comparison
TTSH vs ACIU Comparison
Compare TTSH & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTSH
- ACIU
- Stock Information
- Founded
- TTSH 1985
- ACIU 2003
- Country
- TTSH United States
- ACIU Switzerland
- Employees
- TTSH N/A
- ACIU N/A
- Industry
- TTSH Blank Checks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- TTSH Finance
- ACIU Health Care
- Exchange
- TTSH Nasdaq
- ACIU Nasdaq
- Market Cap
- TTSH 295.2M
- ACIU 332.4M
- IPO Year
- TTSH N/A
- ACIU 2016
- Fundamental
- Price
- TTSH $6.59
- ACIU $2.68
- Analyst Decision
- TTSH
- ACIU Strong Buy
- Analyst Count
- TTSH 0
- ACIU 2
- Target Price
- TTSH N/A
- ACIU $12.00
- AVG Volume (30 Days)
- TTSH 186.3K
- ACIU 132.5K
- Earning Date
- TTSH 11-07-2024
- ACIU 11-05-2024
- Dividend Yield
- TTSH N/A
- ACIU N/A
- EPS Growth
- TTSH N/A
- ACIU N/A
- EPS
- TTSH 0.08
- ACIU N/A
- Revenue
- TTSH $352,075,000.00
- ACIU $48,505,404.00
- Revenue This Year
- TTSH $8.17
- ACIU $85.33
- Revenue Next Year
- TTSH N/A
- ACIU $80.69
- P/E Ratio
- TTSH $82.09
- ACIU N/A
- Revenue Growth
- TTSH N/A
- ACIU 4097200.00
- 52 Week Low
- TTSH $5.68
- ACIU $2.25
- 52 Week High
- TTSH $7.67
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- TTSH 42.58
- ACIU 27.49
- Support Level
- TTSH $6.57
- ACIU $2.62
- Resistance Level
- TTSH $6.98
- ACIU $3.02
- Average True Range (ATR)
- TTSH 0.24
- ACIU 0.15
- MACD
- TTSH -0.02
- ACIU -0.05
- Stochastic Oscillator
- TTSH 29.51
- ACIU 9.52
About TTSH Tile Shop Holdings Inc.
Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.